Allergan plc NYSEAGN announced two deals Monday gaining an exclusive option to acquire neurodegenerative disease company Lysosomal Therapeutics Inc. Cambridge Mass. and a license for rights to four gastrointestinal microbiome programs from Assembly BioScie...
↧